Transcriptional Regulators As Targets for Alcohol Pharmacotherapies

Overview

Journal Handb Exp Pharmacol

Specialty Pharmacology

Date 2018 Mar 30

PMID 29594350

Citations 3

Authors

Antonia M Savarese

Amy W Lasek

Affiliations

Soon will be listed here.

Abstract

Alcohol use disorder (AUD) is a chronic relapsing brain disease that currently afflicts over 15 million adults in the United States. Despite its prevalence, there are only three FDA-approved medications for AUD treatment, all of which show limited efficacy. Because of their ability to alter expression of a large number of genes, often with great cell-type and brain-region specificity, transcription factors and epigenetic modifiers serve as promising new targets for the development of AUD treatments aimed at the neural circuitry that underlies chronic alcohol abuse. In this chapter, we will discuss transcriptional regulators that can be targeted pharmacologically and have shown some efficacy in attenuating alcohol consumption when targeted. Specifically, the transcription factors cyclic AMP-responsive element binding protein (CREB), peroxisome proliferator-activated receptors (PPARs), nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB), and glucocorticoid receptor (GR), as well as the epigenetic enzymes, the DNA methyltransferases (DNMTs) and histone deacetylases (HDACs), will be discussed.

Citing Articles

Decreased voluntary alcohol intake and ventral striatal epigenetic and transcriptional remodeling in male Acss2 KO mice.

Egervari G, Donahue G, Carde N, Alexander D, Hogan C, Shaw J Neuropharmacology. 2024; 265:110258.

PMID: 39653249 PMC: 11771284. DOI: 10.1016/j.neuropharm.2024.110258.

Is DNA methylation in the brain a mechanism of alcohol use disorder?.

Jarczak J, Miszczak M, Radwanska K Front Behav Neurosci. 2023; 17:957203.

PMID: 36778133 PMC: 9908583. DOI: 10.3389/fnbeh.2023.957203.

Tetracycline derivatives reduce binge alcohol consumption in High Drinking in the Dark mice.

Crabbe J, Ozburn A, Hitzemann R, Spence S, Hack W, Schlumbohm J Brain Behav Immun Health. 2021; 4:100061.

PMID: 34589846 PMC: 8474687. DOI: 10.1016/j.bbih.2020.100061.

Targeting Epigenetic Mechanisms to Treat Alcohol Use Disorders (AUD).

Rodriguez F Curr Pharm Des. 2021; 27(30):3252-3272.

PMID: 33535943 PMC: 8778698. DOI: 10.2174/1381612827666210203142539.

References

Vendruscolo L, Estey D, Goodell V, Macshane L, Logrip M, Schlosburg J . Glucocorticoid receptor antagonism decreases alcohol seeking in alcohol-dependent individuals. J Clin Invest. 2015; 125(8):3193-7. PMC: 4563748. DOI: 10.1172/JCI79828. View

Liu X, Hao P, Yang M, Sun J, Mao L, Fan C . The phosphodiesterase-4 inhibitor roflumilast decreases ethanol consumption in C57BL/6J mice. Psychopharmacology (Berl). 2017; 234(16):2409-2419. DOI: 10.1007/s00213-017-4631-8. View

Zhu Z, Hou L, Bollati V, Tarantini L, Marinelli B, Cantone L . Predictors of global methylation levels in blood DNA of healthy subjects: a combined analysis. Int J Epidemiol. 2010; 41(1):126-39. PMC: 3304518. DOI: 10.1093/ije/dyq154. View

Qiao X, Yin F, Ji Y, Li Y, Yan P, Lai J . 5-Aza-2'-deoxycytidine in the medial prefrontal cortex regulates alcohol-related behavior and Ntf3-TrkC expression in rats. PLoS One. 2017; 12(6):e0179469. PMC: 5470731. DOI: 10.1371/journal.pone.0179469. View

Zovkic I, Guzman-Karlsson M, Sweatt J . Epigenetic regulation of memory formation and maintenance. Learn Mem. 2013; 20(2):61-74. PMC: 3549063. DOI: 10.1101/lm.026575.112. View

Ponomarev I, Wang S, Zhang L, Harris R, Mayfield R . Gene coexpression networks in human brain identify epigenetic modifications in alcohol dependence. J Neurosci. 2012; 32(5):1884-97. PMC: 3564514. DOI: 10.1523/JNEUROSCI.3136-11.2012. View

Philibert R, Gunter T, Beach S, Brody G, Madan A . MAOA methylation is associated with nicotine and alcohol dependence in women. Am J Med Genet B Neuropsychiatr Genet. 2008; 147B(5):565-70. PMC: 3685146. DOI: 10.1002/ajmg.b.30778. View

Sakharkar A, Zhang H, Tang L, Baxstrom K, Shi G, Moonat S . Effects of histone deacetylase inhibitors on amygdaloid histone acetylation and neuropeptide Y expression: a role in anxiety-like and alcohol-drinking behaviours. Int J Neuropsychopharmacol. 2014; 17(8):1207-20. PMC: 4140694. DOI: 10.1017/S1461145714000054. View

Wen R, Zhang M, Qin W, Liu Q, Wang W, Lawrence A . The phosphodiesterase-4 (PDE4) inhibitor rolipram decreases ethanol seeking and consumption in alcohol-preferring Fawn-Hooded rats. Alcohol Clin Exp Res. 2012; 36(12):2157-67. PMC: 4335658. DOI: 10.1111/j.1530-0277.2012.01845.x. View

10.

Sacconnay L, Carrupt P, Nurisso A . Human sirtuins: Structures and flexibility. J Struct Biol. 2016; 196(3):534-542. DOI: 10.1016/j.jsb.2016.10.008. View

11.

Bonsch D, Lenz B, Reulbach U, Kornhuber J, Bleich S . Homocysteine associated genomic DNA hypermethylation in patients with chronic alcoholism. J Neural Transm (Vienna). 2004; 111(12):1611-6. DOI: 10.1007/s00702-004-0232-x. View

12.

Bell R, Lopez M, Cui C, Egli M, Johnson K, Franklin K . Ibudilast reduces alcohol drinking in multiple animal models of alcohol dependence. Addict Biol. 2013; 20(1):38-42. PMC: 4017009. DOI: 10.1111/adb.12106. View

13.

Pandey S, Zhang H, Roy A, Xu T . Deficits in amygdaloid cAMP-responsive element-binding protein signaling play a role in genetic predisposition to anxiety and alcoholism. J Clin Invest. 2005; 115(10):2762-73. PMC: 1236671. DOI: 10.1172/JCI24381. View

14.

Silva A, Kogan J, Frankland P, Kida S . CREB and memory. Annu Rev Neurosci. 1998; 21:127-48. DOI: 10.1146/annurev.neuro.21.1.127. View

15.

Sakharkar A, Zhang H, Tang L, Shi G, Pandey S . Histone deacetylases (HDAC)-induced histone modifications in the amygdala: a role in rapid tolerance to the anxiolytic effects of ethanol. Alcohol Clin Exp Res. 2011; 36(1):61-71. PMC: 3208078. DOI: 10.1111/j.1530-0277.2011.01581.x. View

16.

Vendruscolo L, Barbier E, Schlosburg J, Misra K, Whitfield Jr T, Logrip M . Corticosteroid-dependent plasticity mediates compulsive alcohol drinking in rats. J Neurosci. 2012; 32(22):7563-71. PMC: 3375621. DOI: 10.1523/JNEUROSCI.0069-12.2012. View

17.

Franklin K, Hauser S, Lasek A, McClintick J, Ding Z, McBride W . Reduction of alcohol drinking of alcohol-preferring (P) and high-alcohol drinking (HAD1) rats by targeting phosphodiesterase-4 (PDE4). Psychopharmacology (Berl). 2015; 232(13):2251-62. PMC: 4465875. DOI: 10.1007/s00213-014-3852-3. View

18.

Wolstenholme J, Warner J, Capparuccini M, Archer K, Shelton K, Miles M . Genomic analysis of individual differences in ethanol drinking: evidence for non-genetic factors in C57BL/6 mice. PLoS One. 2011; 6(6):e21100. PMC: 3116881. DOI: 10.1371/journal.pone.0021100. View

19.

Crews F, Lawrimore C, Jordan Walter T, Coleman Jr L . The role of neuroimmune signaling in alcoholism. Neuropharmacology. 2017; 122:56-73. PMC: 5493978. DOI: 10.1016/j.neuropharm.2017.01.031. View

20.

Pascual M, Do Couto B, Alfonso-Loeches S, Aguilar M, Rodriguez-Arias M, Guerri C . Changes in histone acetylation in the prefrontal cortex of ethanol-exposed adolescent rats are associated with ethanol-induced place conditioning. Neuropharmacology. 2012; 62(7):2309-19. DOI: 10.1016/j.neuropharm.2012.01.011. View